Introduction: Umbilical cord blood (UCB), previously seen as medical waste, is increasingly
recognized as a valuable source of cells for therapeutic use. The best-known application is …

In light of pioneering findings in the 1980s and an estimation of more than 130 million global
annual births, umbilical cord blood (UCB) is considered to be the most plentiful reservoir of …

Umbilical cord blood transplantation (UCBT) has been performed in the clinic for over 30
years. The biological and immunological characteristics of umbilical cord blood (UCB) have …

Allogeneic hematopoietic stem cell transplantation is a life-saving procedure for
hematopoietic malignancies, marrow failure syndromes, and hereditary immunodeficiency …

Over 20.000 umblical cord blood transplantations (UCBT) have been carried out around the
world. Indeed, UCBT represents an attractive source of donor hematopoietic stem cells …

Umbilical cord blood (UCB) has been shown to be a suitable source of haematopoietic stem
cells (HSCs) for haematopoietic reconstitution. An increase in the number of UCB …

Unfortunately, many patients referred for hematopoietic cell transplant will not have a fully
matched related donor, and finding matched unrelated donors through the registry may be …

Transplantation of umbilical cord blood (UCB) is an attractive alternative source of
hematopoietic stem cells (HSCs). The unique properties of cord blood and its distinct …

Cord blood transplantation is now an established field with enormous potential. UCB
increases access to transplantation therapy for many patients unable to identify a fully …

The potential of allogeneic UCB for HCT and novel cell-based therapies is undervalued and
underutilized. The inventory of high-quality UCB units available from public cord blood …